Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early Echocardiography and ECG Changes Following Radiotherapy in Patients with Stage II-III HER2-Positive Breast Cancer Treated with Anthracycline-Based Chemotherapy with or without Trastuzumab-Based Therapy.
Toma RV, Anca Z, Trifănescu OG, Galeș LN, Folea AR, Stanca L, Bîlteanu L, Anghel RM. Toma RV, et al. Among authors: anghel rm. Med Sci Monit. 2023 Sep 20;29:e941754. doi: 10.12659/MSM.941754. Med Sci Monit. 2023. PMID: 37772333 Free PMC article.
The Efficacy of Immunotherapy in Long-Term Survival in Non-Small Cell Lung Cancer (NSCLC) Associated with the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH).
Rahnea-Nita RA, Stoian AR, Anghel RM, Rebegea LF, Ciuhu AN, Bacinschi XE, Zgura AF, Trifanescu OG, Toma RV, Constantin GB, Rahnea-Nita G. Rahnea-Nita RA, et al. Among authors: anghel rm. Life (Basel). 2023 May 30;13(6):1279. doi: 10.3390/life13061279. Life (Basel). 2023. PMID: 37374062 Free PMC article.
Therapies beyond Physiological Barriers and Drug Resistance: A Pilot Study and Review of the Literature Investigating If Intrathecal Trastuzumab and New Treatment Options Can Improve Oncologic Outcomes in Leptomeningeal Metastases from HER2-Positive Breast Cancer.
Trifănescu OG, Mitrea D, Galeș LN, Ciornei A, Păun MA, Butnariu I, Trifănescu RA, Motaș N, Toma RV, Bîlteanu L, Gherghe M, Anghel RM. Trifănescu OG, et al. Among authors: anghel rm. Cancers (Basel). 2023 Apr 27;15(9):2508. doi: 10.3390/cancers15092508. Cancers (Basel). 2023. PMID: 37173973 Free PMC article.
Validation of a New Prognostic Score in Patients with Ovarian Adenocarcinoma.
Trifanescu OG, Mitrica RI, Gales LN, Marinescu SA, Motas N, Trifanescu RA, Rebegea L, Gherghe M, Georgescu DE, Serbanescu GL, Bashar HH, Dragosloveanu S, Cristian DA, Anghel RM. Trifanescu OG, et al. Among authors: anghel rm. Medicina (Kaunas). 2023 Jan 26;59(2):229. doi: 10.3390/medicina59020229. Medicina (Kaunas). 2023. PMID: 36837431 Free PMC article.
41 results